Trial Profile
Comparison of efficacy and tolerability of venlafaxine and methylphenidate in children and adolescents with Attention Deficit/Hyperactivity Disorder.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Jan 2011
Price :
$35
*
At a glance
- Drugs Methylphenidate (Primary) ; Venlafaxine (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Therapeutic Use
- 07 Jan 2011 New trial record